FdaApplication

ANDA 214842

Back to search

Identifiers

Properties

PropertyValue
applicant_nameEUGIA PHARMA SPECIALITIES LTD
application_typeANDA
approval_date2023-12-26

Products (1)

ProductActive ingredientStrengthDosage form
POSACONAZOLEPOSACONAZOLE300MG/16.7ML (18MG/ML)SOLUTION;INTRAVENOUS

1 product